THE MINIWID-COATER .2. COMPARISON OF ACID RESISTANCE OF ENTERIC-COATED BISACODYL PELLETS COATED WITH DIFFERENT POLYMERS

被引:10
|
作者
SCHMIDT, PC [1 ]
NIEMANN, F [1 ]
机构
[1] UNIV MARBURG, INST PHARMAZEUT TECHNOL, W-3550 MARBURG, GERMANY
关键词
D O I
10.3109/03639049209052412
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Neutral pellets were loaded with bisacodyl and enteric-coated with hydroxypropyl methylcellulose acetate succinate (HPMCAS), carboxymethyl ethylcellulose (CMEC), cellulose acetate trimellitate (CAT), and poly(ethylacrylate, methacrylic acid) (Eudragit L 30 D) in a miniature fluid-bed pan coater called MiniWiD. Gastric juice resistance was tested by dissolution using USP Apparatus 2 (paddle) in 0.1 N hydrochloric acid under sink conditions over 6 hours. As a measure of enteric coating quality the USP specifications were used meaning that no more than 10 % of the drug should be released within 2 hours. Organic-solvent based films of HPMCAS, CMEC and CAT at a coating level of 18 to 25 % provided gastroresistance for more than 6 hours. Aqueous suspensions of HPMCAS and CMEC as well as the ammonium salt aqueous solutions of CAT produced films with a short gastroresistance of below 0.0 hours. By doubling the coating level of water-based HPMCAS films the protection was prolonged to 3.4 h. Enteric coatings were obtained from all aqueous latex dispersions of Eudragit L 30 D at a coating level of 24 %. The alteration of coating temperature between 25 and 45-degrees-C had no significant effect on the release rates, whereas the variation of type and amount of plasticizer led to a different release rate after 2 hours. Best protection was obtained using films plasticized with 20 % of dibutyl phthalate (DBP) allowing a release of only 4 % of the drug in 6 hours although the application temperature was 15-degrees-C below the minimum film-forming temperature (MFT). All coatings dissolved in artificial intestinal fluid within 15 minutes.
引用
收藏
页码:1969 / 1979
页数:11
相关论文
共 37 条
  • [21] Comparison of Dissolution Properties of 2 Enteric-Coated Formulations Containing Mycophenolate Sodium: Myfortic vs Femulan
    Esquivel, A.
    Gonzalez-Ramirez, R.
    Alberu, J.
    Gracida, C.
    Medeiros, M.
    Castaneda-Hernandez, G.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (01) : 353 - 356
  • [22] PHARMACOKINETICS OF 2 ENTERIC-COATED KETOPROFEN PRODUCTS IN HUMANS WITH OR WITHOUT COADMINISTRATION OF OMEPRAZOLE AND COMPARISON WITH DISSOLUTION FINDINGS
    QURESHI, SA
    CAILLE, G
    LACASSE, Y
    MCGILVERAY, IJ
    PHARMACEUTICAL RESEARCH, 1994, 11 (11) : 1669 - 1672
  • [23] Population Pharmacokinetics of Mycophenolic Acid A Comparison between Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Renal Transplant Recipients
    de Winter, Brenda C. M.
    van Gelder, Teun
    Glander, Petra
    Cattaneo, Dario
    Tedesco-Silva, Helio
    Neumann, Irmgard
    Hilbrands, Luuk
    van Hest, Reinier M.
    Pescovitz, Mark D.
    Budde, Klemens
    Mathot, Ron A. A.
    CLINICAL PHARMACOKINETICS, 2008, 47 (12) : 827 - 838
  • [24] Effect of neutralization of poly(methacrylic acid-co-ethyl acrylate) on drug release from enteric-coated pellets upon accelerated storage
    Zu, Yanming
    Luo, Yi
    Ahmed, Salah Uddin
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2007, 33 (04) : 457 - 473
  • [25] Population pharmacokinetics of mycophenolic acid: comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant patients
    de Winter, B. C. M.
    van Gelder, T.
    Glander, P.
    Cattaneo, D.
    Tedesco-Silva, H.
    Neumann, I.
    Hilbrands, L.
    van Hest, R. M.
    Pescovitz, M. D.
    Budde, K.
    Mathot, R. A. A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (01) : 137 - 137
  • [26] BIOAVAILABILITY OF PYRIDOXAL-PHOSPHATE FROM ENTERIC-COATED TABLETS .2. EFFECTS OF GASTRIC-ACIDITY OF HUMANS
    KANIWA, N
    OGATA, H
    AOYAGI, N
    KOIBUCHI, M
    SHIBAZAKI, T
    EJIMA, A
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1985, 33 (09) : 3899 - 3905
  • [27] COMPARISON OF 2 ENTERIC-COATED ACETYLSALICYLIC-ACID PREPARATIONS BY MONITORING STEADY-STATE LEVELS OF SALICYLIC-ACID AND ITS METABOLITES IN PLASMA AND URINE
    EDGAR, B
    BOGENTOFT, C
    LAGERSTROM, PO
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1984, 5 (03) : 251 - 260
  • [28] Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers
    Dharmasaroja, Pornpatr A.
    Sae-Lim, Suvaraporn
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (07) : 649 - 652
  • [29] Influence of the Proton-Pump Inhibitor Pantoprazole on Mycophenolic Acid Pharmacokinetics: A Comparison of Mycophenolate Mofetil (MMF) and Enteric-Coated Mycophenolate Sodium (EC-MPS)
    Rupprecht, K.
    Kees, F.
    Schmidt, Ch.
    Raspe, A.
    Bucher, M.
    Schweda, F.
    Shipkova, M.
    Faerber, L.
    Fischer, W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 510 - 510
  • [30] A comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil to 4 years after kidney transplantation: an analysis from the mycophenolic acid observational renal transplant registry
    Olyaei, Ali
    Wiland, Anne
    Smith, Lonnie
    PHARMACOTHERAPY, 2012, 32 (10): : E247 - E247